| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 01/05/2006 | US20060004188 Chemically reactive carbocyanine dyes incorporating an indolium ring moiety that is substituted at the 3-position by a reactive group or by a conjugated substance |
| 01/05/2006 | US20060004081 Cytotoxic compounds and conjugates |
| 01/05/2006 | US20060004080 Isothiazoloanthrones, isoxazoloanthrones, isoindolanthrones and derivatives thereof a JNK inhibitors and compositions and methods related thereto |
| 01/05/2006 | US20060004069 Agent for preventing or treating neuropathy |
| 01/05/2006 | US20060004067 N-(2-chloro-6-methylphenyl)-2-(6-(4-(3-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide; high efficiency, high yield process to get 2-aminothiazole-5-carboxamides using halogention reaction; by-products inhibition; anticancer, psoriasis |
| 01/05/2006 | US20060004065 5,5,7,9,13-%-Pentamethyl-16-[1-methyl-2-(2-methyl)-1,3-thiazol-4-yl)-ethenyl]-6,6-dioxo-1-ox-a-6 lambda 6-thia-cyclohexadeca-10,13-dien-2-one; epothilones and derivatives; improved properties; anticarcinogenic, -tumor agents |
| 01/05/2006 | US20060004059 Substituted heterocycles for the treatment of diabetes and other diseases |
| 01/05/2006 | US20060004058 Sodium salts of 5-'4-'2-(N-methyl-N-(2-pyridyl) amino) ethoxy!benzyl!thiazolidine -2, 4-dione |
| 01/05/2006 | US20060004056 Di-aryl-substituted-ethan pyridone pde4 inhibitors |
| 01/05/2006 | US20060004051 Compounds |
| 01/05/2006 | US20060004048 Novel biaromatic compounds which activate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereof |
| 01/05/2006 | US20060004047 Piperidine derivatives as ccr5 inhibitors |
| 01/05/2006 | US20060004046 Such as 6-[2-(2,2-difluoro-2-pyridin-2-yl-ethylamino)-4-oxo-4H-thiazol-(5Z)-ylidenemethyl]-4-ethoxy-quinoline-3-carbonitrile; demonstrate CDK1 antiproliferative activity, useful as anti-cancer agent. |
| 01/05/2006 | US20060004045 Thiazolinone unsubstituted quinolines |
| 01/05/2006 | US20060004044 3-glyoxylamideindoles for treating cancer |
| 01/05/2006 | US20060004041 Compounds for treatment of neurodegenerative diseases |
| 01/05/2006 | US20060004033 Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation |
| 01/05/2006 | US20060004030 Asthma, antiallergens; rheumatoid arthritis and atherosclerosis; anticarcinogenic agents; 2-(Benzylthio)-6-{[(1R)-2-hydroxy-1-methylethyl]amino}-4-pyrimidinol |
| 01/05/2006 | US20060004029 Nitrogen-containing aromatic derivatives |
| 01/05/2006 | US20060004017 Quinazoline derivatives as angiogenesis inhibitors |
| 01/05/2006 | US20060004013 Cinnamide compound |
| 01/05/2006 | US20060004009 Ethylenediamine derivatives |
| 01/05/2006 | US20060004005 Triazines derivatives as cell adhesion inhibitors |
| 01/05/2006 | US20060004000 N-aryl-5-substituted-3-yl-1H-indazole-3-carboxamides; amidation of the 1-protected-1H-indazole-3-carboxylic acid, deblocking; hypotensive agents |
| 01/05/2006 | US20060003993 Benzotriazepnes as gastrin and cholecystokinin receptor ligands |
| 01/05/2006 | US20060003986 Such as 4-(4-Methoxy-7-morpholin-4-yl-benzothiazol-2-ylcarbamoyl)-piperidine-1-carboxylic acid tert-butyl ester; for prevention of illnesses based on the modulation of the adenosine system, such as Alzheimer's disease, Parkinson's disease, neuroprotection, schizophrenia, anxiety, pain |
| 01/05/2006 | US20060003374 Coupling amine terminated PNA oligomer or an amine terminated cleavable linker on a solid phase synthesis resin with a benzothiole-2-sulfonyl derivative, capping unprotected amine with actetic anhydride, cleaving over reacted acetyl group, deprotecting benzothiole-2-sulfonyl group, repeating above steps |
| 01/05/2006 | DE102004028973A1 Substituierte Tetrahydro-2H-isochinolin-1-on-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament Substituted tetrahydro-2H-isoquinolin-1-one derivatives, to processes for their preparation and their use as a medicament |
| 01/05/2006 | DE102004027821A1 Benzimidazole, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel Benzimidazoles, process for their preparation and their use as medicaments |
| 01/05/2006 | DE102004026532A1 Substituierte Oxazol-Benzoisothiazoldioxidderivate, Verfahren zu deren Herstellung und deren Verwendung Substituted oxazole Benzoisothiazoldioxidderivate, processes for their preparation and their use |
| 01/05/2006 | CA2810655A1 Modulators of atp-binding cassette transporters |
| 01/05/2006 | CA2571949A1 Modulators of atp-binding cassette transporters |
| 01/05/2006 | CA2571087A1 Novel piperidine derivates as modulators of chemokine receptor ccr5 |
| 01/05/2006 | CA2571002A1 N-(1-(1-benzyl-4-phenyl-1h-imidazol-2-yl)-2,2-dimethylpropyl)benzamide derivatives and related compounds as kinesin spindle protein (ksp) inhibitors for the treatment of cancer |
| 01/05/2006 | CA2570818A1 Indolylalkylamine metabolites as 5-hydroxytrytamine-6 ligands |
| 01/05/2006 | CA2570673A1 Compounds and methods for treating dyslipidemia |
| 01/04/2006 | EP1612208A2 N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation |
| 01/04/2006 | EP1612204A1 Hydrazone derivative |
| 01/04/2006 | EP1611129A1 Cyclic sulfamides for inhibition of gamma-secretase |
| 01/04/2006 | EP1611128A2 Positive allosteric modulators of the nicotinic acetylcholine receptor |
| 01/04/2006 | EP1611121A1 Pyridazinone derivatives as cdk2-inhibitors |
| 01/04/2006 | EP1611120A1 Novel methods for the treatment of inflammatory diseases |
| 01/04/2006 | EP1611112A1 Isoxazole compounds as inhibitors of heat shock proteins |
| 01/04/2006 | EP1611097A1 Indole derivatives useful for the treatment of deseases |
| 01/04/2006 | EP1611096A2 Benzamide modulators of metabotropic glutamate receptors |
| 01/04/2006 | EP1611091A1 Novel compounds |
| 01/04/2006 | EP1611088A2 Hydroxamates as therapeutic agents |
| 01/04/2006 | EP1610812A1 Pharmaceutical preparations comprising acid-stabilised insulin |
| 01/04/2006 | EP1610793A2 Thiazoles useful as inhibitors of protein kinases |
| 01/04/2006 | EP1610780A2 Cyclic protein tyrosine kinase inhibitors |
| 01/04/2006 | EP1610776A2 Ophthalmic compositions for treating ocular hypertension |
| 01/04/2006 | EP1296979B1 HETeroARYL-SUBSTITUTED HETEROCYCLES and their use as pesticides |
| 01/04/2006 | EP1242403B1 2,4-diaminopyrimidine compounds usful as immunosuppressants |
| 01/04/2006 | EP1169298B1 Pharmaceutical compounds |
| 01/04/2006 | EP1147772B1 Use of 1,4-benzothiazepine derivatives for the preparation of a medicament FOR the TREATMENT OF ATRIAL FIBRILLATION |
| 01/04/2006 | EP0885885B1 Pyridone derivatives and herbicides |
| 01/04/2006 | CN1717407A Indolyl derivatives |
| 01/04/2006 | CN1717396A Chk-, Pdk- and Akt-inhibitory pyrimidines, their production and use as pharmaceutical agents |
| 01/04/2006 | CN1717389A Phenyl substituted piperidine compounds for use as PPAR activators |
| 01/04/2006 | CN1717250A Anti-cancer and anti-infectious disease compositions and methods for using same |
| 01/04/2006 | CN1715279A Repinotan analogue,its preparing method and use |
| 01/04/2006 | CN1234705C New hydroxyl indoles, their use as phosphor diesterase 4 inhibitors and method for producing same |
| 01/04/2006 | CN1234693C Indazol compound for inhibiting protein kinase and medicine composition and their application |
| 01/04/2006 | CN1234358C Benzothiazole derivatives |
| 01/03/2006 | US6982336 1,2-dioxetane derivatives, luminescent reagents, luminescence methods and measuring methods |
| 01/03/2006 | US6982332 Hybrid 2-aminotetralin and aryl-substituted piperazine compounds and their use in altering CNS activity |
| 01/03/2006 | US6982276 Polymorphs of an epothilone analog |
| 01/03/2006 | US6982275 Oxidizing a benzylthio- or pyridylmethylthio-substituted indole or benzimidazole derivative |
| 01/03/2006 | US6982272 E.g., 4-acetylamino-N-(1-((4-cyano-1-methylpiperidin-4-yl-carbamoyl)-2 -(cyclohexylethyl)benzamide; Alzheimer's, auto-immune and Crohn's diseases; atherosclerosis; antiarthritic agents; osteoporosis; atherosclerosis |
| 01/03/2006 | US6982268 Useful in the treatment of a variety of central nervous system disorders in humans including anxiety, depression, sleep disorders, attention deficit disorder, or Alzheimer's dementia |
| 01/03/2006 | US6982267 For therapy of metabolic and eating disorders such as obesity and hyperphagia, and therapy of diabetes |
| 01/03/2006 | US6982263 Peptidyl carbamates; treatments for osteoporosis and autoimmune diseases |
| 01/03/2006 | CA2343236C 4,4-biarylpiperidine derivatives |
| 01/03/2006 | CA2247451C Carboxylic acid derivatives having fused rings as retinoic acid receptor agonist |
| 01/03/2006 | CA2244695C Cyclic amic acid derivatives |
| 01/03/2006 | CA2187449C Anti-cancer compounds containing cyclopentaquinazoline ring |
| 12/29/2005 | WO2005123727A1 3-aryl-3-hydroxy- and 3-aryl-3-oxopropionic acid esters as fungicides |
| 12/29/2005 | WO2005123724A1 2,4-diaminoquinazolines for spinal muscular atrophy |
| 12/29/2005 | WO2005123719A1 Compounds and compositions as protein kinase inhibitors |
| 12/29/2005 | WO2005123718A2 Benzimidazolone carboxylic acid derivatives |
| 12/29/2005 | WO2005123715A1 Novel alkyl substituted piperidine derivatives as monoamine neurotransmitter re-uptake inhibitors |
| 12/29/2005 | WO2005123703A2 Alkynyl derivatives as modulators of metabotropic glutamate receptors |
| 12/29/2005 | WO2005123697A1 Quinazoline derivatives |
| 12/29/2005 | WO2005123696A1 Substituted quinazolones as anti-cancer agents |
| 12/29/2005 | WO2005123688A2 3-aminoindazoles |
| 12/29/2005 | WO2005123687A1 Substituted tetrahydro-2h-isoquinolin-1-one derivatives, method for the production thereof, and use of the same as medicaments |
| 12/29/2005 | WO2005123681A1 Saturated and unsaturated 3-pyridyl-benzocycloalkylmethyl-amines for use in the treatment of pains, depressions and anxiety states |
| 12/29/2005 | WO2005123050A2 Five-membered heterocycles useful as serine protease inhibitors |
| 12/29/2005 | WO2005012294A8 2,4-pyrimidinediamine compounds for use in the treatment or prevention of autoimmune diseases |
| 12/29/2005 | WO2005007625A3 Heterocyclic amides with anti-tuberculosis activity |
| 12/29/2005 | US20050288515 Chemical compounds |
| 12/29/2005 | US20050288513 Substituted thiazolidinedione derivative, process for its preparation and its pharmaceutical use |
| 12/29/2005 | US20050288501 Reducing a 2-(protected amino)-3-(piperazin-1-yl, N-morpholinyl, or N-thiomorpholinyl) propanoate, deprotecting the amine, and reacting with t-butylisothiocyanate |
| 12/29/2005 | US20050288358 In which the amino is substituted by arylmethyl- or heteroarylmethyl- group, e.g., 2-Methoxybenzyl)-(2-phenylpyrrolidin-3-yl)-amine and 5-{[2-(3-Chloro-phenyl)-pyrrolidin-3-ylamino]-methyl}-6-methoxy-3-methyl-1,1a,3,7b-tetrahydro-3-aza-cyclopropa[a]naphalen-2-one; neurokinin 1 (Substance P) inhititors |
| 12/29/2005 | US20050288350 Useful in female hormone replacement therapy and as modulators of fertility; therapy of dysfunctional uterine bleeding, dysmenorrhea, endometriosis, leiomyomas (uterine fibroids), hot flashes, mood disorders, meningiomas, cancer; 6-(bis-2,2,2-Trifluoroethyl)amino-4-trifluoromethylcoumarin |
| 12/29/2005 | US20050288347 Certain triazole-based compounds, compositions, and uses thereof |
| 12/29/2005 | US20050288344 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |
| 12/29/2005 | US20050288336 Cysteine protease inhibitors |
| 12/29/2005 | US20050288314 2,4-diaminoquinazolines for spinal muscular atrophy |
| 12/29/2005 | US20050288305 N-biarylmethyl aminocycloalkanecarboxamide derivatives |